These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3321926)

  • 1. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study.
    Lind L; Wengle B; Ljunghall S
    Acta Med Scand; 1987; 222(5):423-7. PubMed ID: 3321926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study.
    Lind L; Wengle B; Wide L; Sörensen OH; Ljunghall S
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):397-402. PubMed ID: 3063290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.
    Lind L; Wengle B; Wide L; Ljunghall S
    Am J Hypertens; 1989 Jan; 2(1):20-5. PubMed ID: 2643969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance.
    Lind L; Lithell H; Skarfors E; Wide L; Ljunghall S
    Acta Med Scand; 1988; 223(3):211-7. PubMed ID: 3281411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol).
    Lind L; Wengle B; Lithell H; Ljunghall S
    J Intern Med; 1992 Apr; 231(4):427-32. PubMed ID: 1588270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism.
    Lind L; Wengle B; Sørensen OH; Wide L; Akerström G; Ljunghall S
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):250-6. PubMed ID: 2644746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of 1,25-(OH)2-vitamin D are not altered by long-term supplementation with alphacalcidol (1-OH-vitamin D3). A double-blind, placebo-controlled study.
    Lind L; Wengle B; Sörensen OH; Ljunghall S
    Exp Clin Endocrinol; 1992; 99(3):151-3. PubMed ID: 1526265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No major metabolic alterations accompany the hypotensive effect of active vitamin D.
    Lind L; Wengle B; Lithell H; Ljunghall S
    Ups J Med Sci; 1991; 96(3):199-204. PubMed ID: 1810079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals.
    Lind L; Wengle B; Lithell H; Ljunghall S
    Scand J Urol Nephrol; 1991; 25(3):233-6. PubMed ID: 1947853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
    Sadek T; Mazouz H; Bahloul H; Oprisiu R; El Esper N; El Esper I; Boitte F; Brazier M; Moriniere P; Fournier A
    Nephrol Dial Transplant; 2003 Mar; 18(3):582-8. PubMed ID: 12584283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance via modification of PGC1α function identifying a possible preventive role of vitamin D analogues in chronic inflammatory state of obesity. A double blind clinical trial study.
    Mirzaei K; Hossein-Nezhad A; Keshavarz SA; Eshaghi SM; Koohdani F; Saboor-Yaraghi AA; Hosseini S; Tootee A; Djalali M
    Minerva Med; 2014 Feb; 105(1):63-78. PubMed ID: 24572452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure.
    Davenport A; Goel S; Mackenzie JC
    Scand J Urol Nephrol; 1993; 27(4):447-51. PubMed ID: 8159916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure.
    Lind L; Pollare T; Hvarfner A; Lithell H; Sørensen OH; Ljunghall S
    Diabetes Res; 1989 Jul; 11(3):141-7. PubMed ID: 2697485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Alfacalcidol on Inflammatory markers and T Cell Subsets in Elderly with Frailty Syndrome: a Double Blind Randomized Controlled Trial.
    Rizka A; Setiati S; Harimurti K; Sadikin M; Mansur IG
    Acta Med Indones; 2018 Jul; 50(3):215-221. PubMed ID: 30333271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis.
    Ljunghall S; Althoff P; Fellström B; Marjanovic B; Nisell J; Weiss L; Wide L
    Nephron; 1990; 55(4):380-5. PubMed ID: 2392190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial.
    Mozaffari-Khosravi H; Loloei S; Mirjalili MR; Barzegar K
    Blood Press Monit; 2015 Apr; 20(2):83-91. PubMed ID: 25350782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oral calcium supplementation reduces diastolic blood pressure in end stage renal disease. A randomized, double-blind, placebo controlled study.
    Petersen LJ; Rudnicki M; Højsted J
    Int J Artif Organs; 1994 Jan; 17(1):37-40. PubMed ID: 8188397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial.
    Witham MD; Ireland S; Houston JG; Gandy SJ; Waugh S; Macdonald TM; Mackenzie IS; Struthers AD
    Hypertension; 2014 Apr; 63(4):706-12. PubMed ID: 24420547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial.
    McCarron DA; Morris CD
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):825-31. PubMed ID: 3904559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial.
    Scragg R; Slow S; Stewart AW; Jennings LC; Chambers ST; Priest PC; Florkowski CM; Camargo CA; Murdoch DR
    Hypertension; 2014 Oct; 64(4):725-30. PubMed ID: 24980662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.